This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
This approval has come from the company's finished dosage form manufacturing facility
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
GL0034 is a novel, investigational glucagon-like peptide 1 receptor agonist (GLP-1RA) being studied for the treatment of type 2 diabetes and obesity
Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support
It is administered as a single infusion 30 minutes prior to the start of each chemotherapy cycle that helps prevent, both, acute and delayed phases of CINV
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease
Subscribe To Our Newsletter & Stay Updated
